Steven M. Fruchtman's Insider Trades & SAST Disclosures
Steven M. Fruchtman's most recent trade in Traws Pharma Inc. was a trade of 23,111 Common Stock done . Disclosure was reported to the exchange on March 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven M. Fruchtman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 23,111 | 83,519 (0%) | 0% | - | Common Stock | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 23,111 | 46,222 | - | - | Restricted Stock Units | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 13 Mar 2024 | 8,727 | 74,792 (0%) | 0% | 0.9 | 7,854 | Common Stock |
| Traws Pharma Inc. | Steven Fruchtman M. | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 21,320 | 21,320 | - | - | Restricted Stock Units | |
| Traws Pharma Inc. | Fruchtman Steven M. | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 21,320 | 69,620 (0%) | 0% | - | Common Stock | |
| Traws Pharma Inc. | M. Fruchtman Steven | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 07 Feb 2024 | 9,212 | 60,408 (0%) | 0% | 0.7 | 6,172 | Common Stock |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 12,567 | 12,567 | - | - | Restricted Stock Units | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 12,567 | 53,044 (0%) | 0% | - | Common Stock | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 02 Aug 2023 | 4,744 | 48,300 (0%) | 0% | 1.0 | 4,791 | Common Stock |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2023 | 207,000 | 207,000 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2023 | 69,333 | 69,333 | - | - | Restricted Stock Units | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 21,320 | 42,640 | - | - | Restricted Stock Units | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 21,320 | 47,454 (0%) | 0% | - | Common Stock | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.36 per share. | 07 Feb 2023 | 6,977 | 40,477 (0%) | 0% | 1.4 | 9,489 | Common Stock |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 12,566 | 30,696 (0%) | 0% | - | Common Stock | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 12,566 | 25,134 | - | - | Restricted Stock Units | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Aug 2022 | 4,562 | 26,134 (0%) | 0% | 1.3 | 6,022 | Common Stock |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 191,880 | 191,880 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 63,960 | 63,960 | - | - | Restricted Stock Units | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 28 Sep 2021 | 2,381 | 18,130 (0%) | 0% | 4.2 | 10,000 | Common Stock |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 113,000 | 113,000 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 37,700 | 37,700 | - | - | Restricted Stock Unit | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 706,000 | 706,000 | - | - | Stock Appreciation Right | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 16 Feb 2021 | 20,000 | 236,226 (0%) | 0% | 1 | 20,000 | Common Stock |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 0.26 per share. | 25 Nov 2020 | 40,000 | 216,226 (0%) | 0% | 0.3 | 10,360 | Common Stock |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 1,273,800 | 1,273,800 | - | - | Stock Appreciation Right | |
| Traws Pharma Inc. | Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 19 May 2020 | 26,800 | 176,226 (0%) | 0% | 0.4 | 9,857 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges